XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balances at Dec. 31, 2017 $ 50,337 $ 2 $ 122,950 $ (102) $ (72,513)
Balances (in shares) at Dec. 31, 2017   16,670,000      
Issuance of common stock in connection with employee stock purchase plan 207   207    
Issuance of common stock in connection with employee stock purchase plan (in shares)   56,000      
Issuance of common stock in connection with exercise of stock options 2,829   2,829    
Issuance of common stock in connection with exercise of stock options (in shares)   521,000      
Issuance of common stock in connection with public and at-the-market offerings, net of offering costs 54,048   54,048    
Issuance of common stock in connection with public and at-the-market offerings, net of offering costs (in shares)   6,893,000      
Stock-based compensation expense 4,280   4,280    
Unrealized (loss) gain on marketable securities 75     75  
Net loss (44,348)       (44,348)
Balances at Dec. 31, 2018 67,428 $ 2 184,314 (27) (116,861)
Balances (in shares) at Dec. 31, 2018   24,140,000      
Issuance of common stock in connection with employee stock purchase plan 307   307    
Issuance of common stock in connection with employee stock purchase plan (in shares)   45,000      
Issuance of common stock in connection with exercise of stock options 1,143   1,143    
Issuance of common stock in connection with exercise of stock options (in shares)   274,000      
Issuance of common stock and pre-funded warrants in connection with public and at-the-market offerings, net of offering costs 64,503 $ 1 64,502    
Issuance of common stock and pre-funded warrants in connection with public and at-the-market offerings, net of offering costs (in shares)   4,625,000      
Stock-based compensation expense 4,876   4,876    
Unrealized (loss) gain on marketable securities 78     78  
Net loss (78,254)       (78,254)
Balances at Dec. 31, 2019 60,081 $ 3 255,142 51 (195,115)
Balances (in shares) at Dec. 31, 2019   29,084,000      
Issuance of common stock in connection with employee stock purchase plan 366   366    
Issuance of common stock in connection with employee stock purchase plan (in shares)   60,000      
Issuance of common stock in connection with exercise of stock options $ 490   490    
Issuance of common stock in connection with exercise of stock options (in shares) 127,376 127,000      
Issuance of common stock and pre-funded warrants in connection with public and at-the-market offerings, net of offering costs $ 153,572 $ 2 153,570    
Issuance of common stock and pre-funded warrants in connection with public and at-the-market offerings, net of offering costs (in shares)   18,688,000      
Stock-based compensation expense 6,256   6,256    
Foreign currency translation adjustment 19     19  
Unrealized (loss) gain on marketable securities (59)     (59)  
Net loss (80,893)       (80,893)
Balances at Dec. 31, 2020 $ 139,832 $ 5 $ 415,824 $ 11 $ (276,008)
Balances (in shares) at Dec. 31, 2020   47,959,000